M33 Growth I L.P.

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
M33 Growth I L.P.'s trades of Starling Oncology, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
3.20
Quantity 1,122,793
Value US$3,592,938
Transaction date
Proposed sale
Price
3.06
Quantity 1,796,468
Value US$5,497,192
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-05 2025-09-04
S Sale
1,331 -3.0%
453.86
US$2,359,239 		1,331 -3.0% 453.86 US$2,359,239
2025-09-05 2025-09-04
S Sale
93,469 +6.9%
392.07
US$4,920,689 		93,469 +6.9% 392.07 US$4,920,689
2025-06-09 2025-06-05
S Sale
15,107 +22.7%
57.99
US$3,270,780 		15,107 +22.7% 57.99 US$3,270,780
2025-06-09 2025-06-05
S Sale
673,676 -4.6%
3.05
US$2,054,712 		673,676 -4.6% 3.05 US$2,054,712
2025-06-05 2025-06-05
PrS Proposed sale
1,122,793
3.20
US$3,592,938 		1,122,793 3.20 US$3,592,938
2025-05-22 2025-05-20
S Sale
203,532 -13.1%
2.71
US$552,162 		203,532 -13.1% 2.71 US$552,162
2025-05-22 2025-05-20
S Sale
1,796,468 -10.9%
2.71
US$4,873,638 		1,796,468 -10.9% 2.71 US$4,873,638
2025-05-20 2025-05-20
PrS Proposed sale
1,796,468
3.06
US$5,497,192 		1,796,468 3.06 US$5,497,192